These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 9754780
1. Elevated ovarian cancer marker (CA-125) in cirrhotic patients with intractable ascites. Zamir D, Jarchovsky J, Singer C, Weiner P. J Clin Gastroenterol; 1998 Sep; 27(2):154-5. PubMed ID: 9754780 [No Abstract] [Full Text] [Related]
2. Cirrhotic ascites, ovarian carcinoma, and CA-125. Rubin J, Rockey DC. South Med J; 1999 Feb; 92(2):248-50. PubMed ID: 10071679 [Abstract] [Full Text] [Related]
3. Elevated CA 125 and ascites: not always malignancy. Lockhart CJ, McVeigh GE, Harbinson MT. Ir J Med Sci; 2008 Mar; 177(1):63-6. PubMed ID: 17661125 [Abstract] [Full Text] [Related]
6. Ovarian fibroma with marked ascites and elevated serum levels of CA-125 in a young girl. Sugiyama A, Urushihara N, Fukumoto K, Fukuzawa H, Nagae H, Watanabe K, Mitsunaga M, Hasegawa S, Koyama M. J Pediatr Surg; 2011 May; 46(5):1001-4. PubMed ID: 21616270 [Abstract] [Full Text] [Related]
10. Vascular endothelial growth factor expression correlates with serum CA125 and represents a useful tool in prediction of refractoriness to platinum-based chemotherapy and ascites formation in epithelial ovarian cancer. Masoumi-Moghaddam S, Amini A, Wei AQ, Robertson G, Morris DL. Oncotarget; 2015 Sep 29; 6(29):28491-501. PubMed ID: 26143638 [Abstract] [Full Text] [Related]
11. How to interpret serum CA 125 levels in patients with serosal involvement? A clinical dilemma. Sevinc A, Camci C, Turk HM, Buyukberber S. Oncology; 2003 Sep 29; 65(1):1-6. PubMed ID: 12837976 [Abstract] [Full Text] [Related]
12. The clinical value of tumour markers in the management of ovarian cancer. Rustin GJ. Ann Clin Biochem; 1996 Jul 29; 33 ( Pt 4)():284-9. PubMed ID: 8836386 [No Abstract] [Full Text] [Related]
17. Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis. Fabris C, Basso DA, Leandro G, Meggiato T, Elba S, Panozzo MP, Del Favero G, Fogar P, Di Mario F, Naccarato R. Cancer; 1991 Oct 15; 68(8):1795-8. PubMed ID: 1717126 [Abstract] [Full Text] [Related]
18. Cancer antigen-125 and ICAM-1 are together responsible for ascites in liver cirrhosis. Chowdhury MA, Xiubin Z, Wei H, Chenghao G. Clin Lab; 2014 Oct 15; 60(4):653-8. PubMed ID: 24779300 [Abstract] [Full Text] [Related]
19. Elevation of CA-125 level is due to abdominal distension in liver transplantation candidates. Deschênes M, Michel RP, Alpert E, Barkun JS, Metrakos P, Tchervenkov J. Transplantation; 2001 Nov 15; 72(9):1519-22. PubMed ID: 11707739 [Abstract] [Full Text] [Related]
20. Cancer antigen 125 associated with multiple benign and malignant pathologies. Miralles C, Orea M, España P, Provencio M, Sánchez A, Cantos B, Cubedo R, Carcereny E, Bonilla F, Gea T. Ann Surg Oncol; 2003 Mar 15; 10(2):150-4. PubMed ID: 12620910 [Abstract] [Full Text] [Related] Page: [Next] [New Search]